Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€21.85

€21.85

-0.680%
-0.15
-0.680%
-
 
10:21 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Schott Pharma AG & Co. Kgaa Stock

Schott Pharma AG & Co. Kgaa shows a slight decrease today, losing -€0.150 (-0.680%) compared to yesterday.

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: SCHOTT Pharma with strong third quarter and on track for planned growthPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-News: SCHOTT Pharma with strong third quarter and on track for planned growth
EQS-News: SCHOTT Pharma with strong third quarter and on track for planned growth
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidancePhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
EQS-News: SCHOTT Pharma mit robustem erstem Halbjahr und starkem CashflowPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
EQS-News: SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow
EQS-News: SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow